85
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration

, , , , , , & show all
Pages 719-731 | Published online: 02 Feb 2018

References

  • GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
  • McGuireWPHoskinsWJBradyMFCyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerNew Engl J Med19963341167494563
  • SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerNew Engl J Med2006355242542255017167137
  • GelderblomHVerweijJNooterKSparreboomACremophorELThe drawbacks and advantages of vehicle selection for drug formulationEur J Cancer200137131590159811527683
  • WeissRBDonehowerRCWiernikPHHypersensitivity reactions from TaxolJ Clin Oncol199087126312681972736
  • ShammaRNBashaMSoluplus®: a novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparationPowder Technol2013237406414
  • DianLHYuEJChenXNEnhancing oral bioavailability of quercetin using novel soluplus polymeric micellesNanoscale Res Lett2014912406241626088982
  • WuSHHopkinsWKCharacteristics of d-α-tocopheryl PEG1000 succinate for applications as an absorption enhancer in drug delivery systemsPharm Tech1999235269
  • GuoYYLuoJTanSWOtienoBOZhangZPThe applications of Vitamin E TPGS in drug deliveryEur J Pharm Sci201349217518623485439
  • ShiehMJHsuCYHuangLYChenHYHuangFHLaiPSReversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cellsJ Control Release2011152341842521435362
  • FengSSMeiLAnithaPGanCWZhouWPoly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxelBiomaterials200930193297330619299012
  • WeissMJWongJRHaCSDequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulationProc Natl Acad Sci U S A19878415544454483474661
  • ZhangYLiRJYingXTargeting therapy with mitosomal daunorubicin plus amiodipine has the potential to circumvent intrinsic resistant breast cancerMol Pharm20118116217521062083
  • YingXWenHLuWLDual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsJ Control Release201014118319219799948
  • RamasamyTRuttalaHBGuptaBSmart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive reviewJ Control Release201725822625328472638
  • RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
  • MatsumuraYMaedaHAA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCSCancer Res19864612 Pt 1638763922946403
  • WangATLiangDSLiuYJQiXRRoles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumorsBiomaterials20155316017225890716
  • YuYWangZHZhangLMitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanomaBiomaterials20123361808182022136714
  • ZhangLYaoHJYuYMitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cellsBiomaterials201233256558221983136
  • YaoHYJuRJWangXXThe antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral deliveryBiomaterials201132123285330221306774
  • Henry-MowattJDiveCMartinouJCJamesDRole of mitochondrial membrane permeabilization in apoptosis and cancerOncogene200423162850286015077148
  • RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
  • LiNZhangCXWangXXDevelopment of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathwaysBiomaterials201334133366338023410681
  • SundaramoorthyPRamasamyTMishraSKEngineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cellsActa Biomater20164222023127395829